Hamostaseologie

Article	Citations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	46
Mitteilungen aus der Vorstandsarbeit	40
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	23
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	22
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	21
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	19
Mansoor’s self-report tool for cardiovascular risk assessment predicts adverse in-hospital events in patients with pulmonary embolism	18
	18
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	18
Recombinant ADAMTS13 treatment in a pregnant patient with hereditary thrombotic thrombocytopenic purpura	14
Current diagnostic and therapeutic standard of iliac vein compression syndrome (May-Thurner syndrome) in children, adolescents and young adults. A survey among national thrombosis experts	14
Immune tolerance achievement by low dose factor VIII in PUPs and MTPs under prophylaxis with emicizumab: two case reports	14
Participation of T helper cell-mediated negative regulation of coagulation in human arterial thrombosis	14
Preanalytical quenching of FVIII using FVIII-inhibitors improves the specificity of functional emicizumab testing	13
	12
Possible immune reaction to COVID-19 vaccination - a case report	12
Diagnostic challenges of Thrombotic Thrombocytopenic Purpura: Results from a cohort of 3,100 individual patients in a time period of 21 months	12
Komplementdysregulation als Biomarker für Post Covid	11
Sulodexid: Neue Hoffnung bei retinalen Gefäßerkrankungen	10
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	10
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	9
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	9
Subsegmental Pulmonary Embolism	9
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	9
	8

The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	8
Insights in pain processing of affected versus non-affected structures	7
Impaired hemostatic capacity in patients with low von Willebrand factor	7
Development of Antidrug Inhibitory Antibodies against Polyethylene Glycol after Treatment with PEGylated Factor VIII Therapeutic	7
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II	7
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Follow-up evaluation of real-life-data documented by smart medication eDiary	7
A Survey on anticoagulation in patient with ITP	7
Immune modulation by the endothelial protein C receptor (EPCR) in cancer progression	6
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?	6
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	6
Platelets are pre-activated during thrombocytopenia in a subset of early malaria infections	6
Platelets in Myocardial Ischemia/Reperfusion Injury	6
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	5
Influenza infections destabilize established immune tolerance in HemA mice	5
Reference Intervals in Coagulation Analysis	5
GTH News	5
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score	5
Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemost	5
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	5
Management of Antithrombin Deficiency in Pregnancy	5
Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank	5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	5
Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia	4
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	4
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	4
Telomere length is associated with increased risk of cardiovascular events in hemodialysis patients	4
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	4
Elevated plasminogen activator inhibitor-1 is not associated with impaired plasmin formation and thrombotic risk after low-grade coagulation activation in vivo	4
Evaluating the individual risk of venous thrombo-embolism in patients with liver cirrhosis: Usefulness of in vivo and ex vivo thrombin generation parameters	4
EMIIL - Non-interventional study to investigate the effectiveness of Emicizumab under real-world conditions in pediatric, adolescent, adult and elderly patients with hemophilia A (PwHA) with and witho	4
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	4
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	4
Recurrent Venous Thrombosis in a Hypofibrinogenemic Patient Despite a Heterozygous Deletion of the Fibrinogen Gene Cluster and Hemizygous FGB p.Pro265Leu Variant Mimicking a Homozygous Genotype	4
Non-clinical pharmacodynamic effects and immunogenicity assessment of prophylactic immune modulation prior to gene therapy dose administration in C57BL/6 mice	4
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien	4
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	4
Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etr	4
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	4
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	4
Survey on the care reality of people with mild hemophilia A and B in Germany - the burden of mild hemophilia	4
HEM-POWR study: Subgroup analysis evaluating the real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Germany	3
Inhibition of cold-induced apoptosis of platelet concentrates improves platelet functionality and half-life	3
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	3
Communication in Healthcare: Global challenges in the 21st Century	3
Endogenous FVIII activity and procedure-related FVIII use and bleeding: post hoc analysis of GENEr8-1	3
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer	3
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	3
Bleeding Risk in Patients with Cancer	3
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors	3
GTH News	3

Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	3
The Use of Large Animal Models in Trauma and Bleeding Studies	3
Treatment of Inherited Platelet Disorders: Current Status and Future Options	3
Acquired von Willebrand Syndrome in Children	3
Digital joint discovery tool to support hemophilia patient education	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Pharmazeutische Unternehmen außerhalb der USA unter Druck	3
Endothelial protein C receptor signaling regulates myeloid-biased hematopoiesis under stress and in aging	3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	3
Haemostaseological pearls	3
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	2
Ontogeny of peripheral blood platelet GPIIb/IIIa activation and granule release in preterm and term neonates	2
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia®) Activity Using Reagent-/Platform-Specific Conversion Factors	2
Treatment of Atypical Clots	2
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	2
The Timed Up and Go Test in Patients with Haemophilia: Assessing Reliability, Validity, and Predictive Variables	2
Correlation between coagulation factor residual activities and detection rate of diseasecausing variants in Rare Bleeding Disorders	2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	2
Treatment of a patient with von Willebrand disease type 2B and severe thrombocytopenia due to mutation p.V1316M with thrombopoietin receptor agonist Avatrombopag	2
Identification of key regulators of procoagulant COAT platelet generation by quantitative phosphoproteomic analysis and phosphoflow	2
	2
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	2
Periinterventional management of edoxaban in major procedures: results from the DRESDEN NOAC REGISTRY	2
Subsequent vaccinations in VITT patients other than SARS-CoV2 vaccination	2
Saliva and urine from persons with hemophilia A trigger coagulation bypassing factor VIII	2
The effect of prophylactic corticosteroid treatment on adeno-associated virus-mediated gene therapy and potential mechanisms of action	2
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	2
Interim 52-Week analysis of immunogenicity to the vector capsid and transgene-expressed human FVIII in GENEr8-1, a phase 3 clinical study of valoctocogene roxaparvovec, an AAV5-mediated gene therapy f	2
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	2
Sequential combinations of rapid immunoassays for quick recognition of heparin-induced thrombocytopenia	2
The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation	2
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	1
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	1
Venous Thromboembolism Issues in Women	1
Association Between Major Bleeding and In-Hospital Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes	1
Liver damage promotes thromboinflammatory T-cell responses	1
Thrombocytopenia in patients with cardiogenic shock treated with extracorporal life support system versus conservative treatment	1
Hemophilia and Concussion Outcome Study (HeCos): Neurological Status of Children with Hemophilia—Prevalence and Relevance of Mild Traumatic Brain Injury	1
	1
Isolation of vWF-specific antibody fragments from phage-displayed scFv libraries	1
Characterization of the influence of heat- and acid-treatment on the FVIII-antibody interaction in order to improve inhibitor diagnostics	1
Comparison of closure time and whole blood impedance aggregometry to light transmission platelet aggregometry for the assessment of platelet response to aspirin and P2Y12 inhibitor therapies: a large-	1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting	1
The Role of Platelet microRNAs in Cancer	1
Investigating the interaction of circulating von Willebrand factor with polymorphonuclear leukocytes ex vivo	1
Direct oral anticoagulants cause placental vascular abnormalities and epigenetic reprogramming in placenta and the offspring	1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)	1
Impaired signaling pathways in Glanzmann thrombasthenia platelets	1
Global seroprevalence of neutralizing antibodies against adeno-associated virus (AAV) serotypes of relevance to gene therapy	1
Second- and third-generation FVIII-specific CAR Treg responses to FVIII are functionally affected by the combination of FVIII-specific scFvs and intracellular costimulatory domains	1
In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis	1
Understanding the biomolecular corona formation at the nano-bio interface	1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern	1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Animal and Cellular Models in Thrombosis and Hemostasis	1
GTH News	1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	1
Healthcare professionals (HCPs) in Austria are positive about gene therapy, but expressed a need for a more topic related education	1
Acquired von Willebrand Syndrome Type 2 in Children with Severe Pulmonary Arterial Hypertension	1
Improvements in health-related quality of life in adults with severe or moderately severe haemophilia B after receiving etranacogene dezaparvovec gene therapy	1
Investigation of Differential Interaction between GGCX and VKD Clotting Factors by an In Silico Approach	1
Establishment of an ex vivo assay to investigate thrombus formation using platelet concentrates	1
Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B	1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis	1
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0
Plasma-derived extracellular vesicles: a look at the preanalytics	0
G-BA entscheidet Festgruppe für (plasmatischen) Blutgerinnungsfaktor VIII	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
GTH News	0
Oral Anticoagulation and Mortality in Cases with Intracranial Bleeding: Analysis of Nationwide Prescription and Hospitalization Data	0
Pitfalls in Coagulation Testing	0
The Impact of Genetic and Acquired Risk Factors on Thromboembolic Events: A Retrospective Study	0
In Contrast to Full-Length Factor VIII, the Calnexin (ER Chaperone) and LMAN1 (ERGIC transporter) Knockouts Have Minimal Effect on the Secretion of B-Domain-Deleted Factor VIII: Implication for Gene T	0

A hierarchical network of Src, Syk, Btk and PKC controls GPVI-dependent human platelet activation	0
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause	0
A novel solid phase assay for the detection of fibrinolytic activities	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
The effects of single and combined knockouts of GABARAPs proteins family on FVIII secretion	0
Women and Hereditary Bleeding Disorders	0
Establishment of an in vitro assay to detect antibody-mediated procoagulant platelet formation on a single cell level in real time	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec (CSL222) vs. extended half-life Factor IX therapies for severe or moderately severe hemophilia B	0
	0
Update on Cancer-Associated Venous Thromboembolism in Children	0
	0
Disorders of Thrombosis and Hemostasis in Cancer	0
Heme-triggered effects on blood coagulation: a bioinformatics approach based on experimental data	0
Alternative polyadenylation regulates VEGF-coreceptor NRP1	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Blutverlust bei Frauen im gebärfähigen Alter aufgrund oraler Antikoagulanzien gegen venöse Thromboembolien	0
Monitoring of emicizumab in acquired hemophilia A	0
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
Laboratory Monitoring in Patients Receiving Emicizumab	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Priv.-Doz. Dr. med. Rainer B. Zotz	0
The effect of DNA methylation on inhibitor development in haemophilia A patients treated with FVIII concentrates	0
Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)	0
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten	0
The impact of enhanced platelet turnover on platelet reactivity in healthy humans	0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature	0
Developing an assay to distinguish between HIT and VITT antibodies	0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors	0
A novel, homozygous mutation in GFI1B causing inherited thrombocytopenia with Glanzmann-like platelet dysfunction	0
	0
At the forefront of the introduction of gene therapy in hemophilia A and B: Design and implementation of an innovative software platform ("smart medication Gene") for gene therapy	0
Durability of Factor IX activity and bleeding rate in people with severe or moderately severe haemophilia B after long-term follow-up in the phase 1/2 Study of AMT-060, and phase 2b and phase 3 studie	0
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	0
Gut microbiota promotes arterial thrombus formation in hyperlipidemic Ldlr-/- mouse model	0
	0
Cardiovascular biomarkers for the prediction of adverse cardiovascular events and mortality in patients with cancer	0
Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A	0
Developing an assay to determine the individual osteoclastogenic potential of patients with coagulation disorders in-vitro: challenges and pitfalls	0
Aktueller Stand zur Reform der Gebührenordnung für Ärzte (GOÄ)	0
The phenotypic and genetic assessment of hereditary antithrombin deficiency in 215 patients from the Rhein-Ruhr area in Germany	0
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
Aggregates of non-muscle myosin IIA in the erythrocytes associate with GATA1-related thrombocytopenia	0
Bridging the gap between coagulation in experimental research and clinical hemostaseology – a modified rotational thromboelastometry assay to show the pro-coagulatory effect of senescence on human blo	0
VTE Risk Assessment and Prevention in Pregnancy	0
	0
Grundlagen zur Anwendung von Andexanet	0
Monitoring of unfractionated heparin in critical ill ICU patients: a prospective study comparing aPTT and point-of-care viscoelastic testing with IN /HI ratio to anti-Xa	0
Platelet GPIIbIIIa enriched membrane protrusions (Tether) in healthy and diseased individuals	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI Activity	0
Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic revi	0
Agenesis of vena cava inferior (AVCI) and Hypereosinophilic Syndrome (HES): two rare causes of severe thrombosis and its challenging treatment in adolescents	0
Sensitive and unambiguous measurement of the activated contact activation factor XII	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
Von Willebrand Disease—Specific Aspects in Women	0
Cytometry, Immunofluorescence Microscopy, and Light Transmission Aggregometry in the Diagnosis of Platelet Functional Disorders	0
	0
Pathophysiology of Trauma-Induced Coagulopathy	0
Erratum to: Congenital Fibrinogen Deficiencies: Not So Rare	0
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	0
Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All	0
Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma	0
Relation of FVIII activity levels with global assays of hemostasis in persons with hemophilia A	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
Women's Health Issues in Thrombosis and Haemostasis	0
New Anticoagulants in Neonates, Children, and Adolescents	0
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	0
Von Willebrand-disease_ a patient with a variant of uncertain significance: phenotype like type 1, genotype like type 3	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
Intrinsic difference in cellular response between full-length and B-domain deleted FVIII HEK293 secreting cells: implication for gene therapy	0
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor	0
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	0
The Post-VTE Functional Status Scale for assessment of functional limitations in patients with venous thromboembolism: construct validity and responsiveness in a prospective cohort study	0
Randomized-controlled cross-over pilot study on the effectiveness of manual lymphatic drainage in patients with hemophilic arthropathy	0
Pulmonary Embolism: Don't Start Me to Talkin'	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
Platelet hyperactivation and neutrophil extracellular traps promote thrombo-inflammation and glomerular endothelial dysfunction in diabetic kidney disease	0
Structural Characterization of Factor VIII B Domain to Generate an All Atom Full-Length Structure of the Coagulation Factor VIII Protein	0
Leveraging medical-AI to speed up Cold Agglutinin Disease detection	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
	0
Production of FVIII-specific iTregs using tolerogenic dendritic cells	0
Assessment of platelet abnormalities in patients with DiGeorge Syndrome by immunofluorescence microscopy on the blood smear	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel	0
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)	0
	0
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	0
Utility of ACMG classification to support interpretation of molecular genetic test results in patients with FVII deficiency	0
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review	0
Platelet responsiveness in the post-acute phase of pulmonary embolism	0